Literature DB >> 28623086

The Transcription Factor T-bet Limits Amplification of Type I IFN Transcriptome and Circuitry in T Helper 1 Cells.

Shigeru Iwata1, Yohei Mikami1, Hong-Wei Sun2, Stephen R Brooks2, Dragana Jankovic3, Kiyoshi Hirahara4, Atsushi Onodera5, Han-Yu Shih1, Takeshi Kawabe6, Kan Jiang1, Toshinori Nakayama7, Alan Sher3, John J O'Shea8, Fred P Davis9, Yuka Kanno10.   

Abstract

Host defense requires the specification of CD4+ helper T (Th) cells into distinct fates, including Th1 cells that preferentially produce interferon-γ (IFN-γ). IFN-γ, a member of a large family of anti-pathogenic and anti-tumor IFNs, induces T-bet, a lineage-defining transcription factor for Th1 cells, which in turn supports IFN-γ production in a feed-forward manner. Herein, we show that a cell-intrinsic role of T-bet influences how T cells perceive their secreted product in the environment. In the absence of T-bet, IFN-γ aberrantly induced a type I IFN transcriptomic program. T-bet preferentially repressed genes and pathways ordinarily activated by type I IFNs to ensure that its transcriptional response did not evoke an aberrant amplification of type I IFN signaling circuitry, otherwise triggered by its own product. Thus, in addition to promoting Th1 effector commitment, T-bet acts as a repressor in differentiated Th1 cells to prevent abberant autocrine type I IFN and downstream signaling. Published by Elsevier Inc.

Entities:  

Keywords:  ChIP-seq; JAK-STAT pathway; RNA-seq; STAT; T helper cells; T-bet; immunoregulation; interferon gamma; signal transducer and activator of transcription; transcription; type I interferons

Mesh:

Substances:

Year:  2017        PMID: 28623086      PMCID: PMC5523825          DOI: 10.1016/j.immuni.2017.05.005

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  45 in total

1.  Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5.

Authors:  Xiang-Ping Yang; Kamran Ghoreschi; Scott M Steward-Tharp; Jaime Rodriguez-Canales; Jinfang Zhu; John R Grainger; Kiyoshi Hirahara; Hong-Wei Sun; Lai Wei; Golnaz Vahedi; Yuka Kanno; John J O'Shea; Arian Laurence
Journal:  Nat Immunol       Date:  2011-01-30       Impact factor: 25.606

Review 2.  Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors.

Authors:  Kenya Honda; Akinori Takaoka; Tadatsugu Taniguchi
Journal:  Immunity       Date:  2006-09       Impact factor: 31.745

3.  Near-optimal probabilistic RNA-seq quantification.

Authors:  Nicolas L Bray; Harold Pimentel; Páll Melsted; Lior Pachter
Journal:  Nat Biotechnol       Date:  2016-04-04       Impact factor: 54.908

Review 4.  Interferons, immunity and cancer immunoediting.

Authors:  Gavin P Dunn; Catherine M Koebel; Robert D Schreiber
Journal:  Nat Rev Immunol       Date:  2006-11       Impact factor: 53.106

5.  Blockade of chronic type I interferon signaling to control persistent LCMV infection.

Authors:  Elizabeth B Wilson; Douglas H Yamada; Heidi Elsaesser; Jonathan Herskovitz; Jane Deng; Genhong Cheng; Bruce J Aronow; Christopher L Karp; David G Brooks
Journal:  Science       Date:  2013-04-12       Impact factor: 47.728

Review 6.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.

Authors:  J E Darnell; I M Kerr; G R Stark
Journal:  Science       Date:  1994-06-03       Impact factor: 47.728

7.  Ensembl 2016.

Authors:  Andrew Yates; Wasiu Akanni; M Ridwan Amode; Daniel Barrell; Konstantinos Billis; Denise Carvalho-Silva; Carla Cummins; Peter Clapham; Stephen Fitzgerald; Laurent Gil; Carlos García Girón; Leo Gordon; Thibaut Hourlier; Sarah E Hunt; Sophie H Janacek; Nathan Johnson; Thomas Juettemann; Stephen Keenan; Ilias Lavidas; Fergal J Martin; Thomas Maurel; William McLaren; Daniel N Murphy; Rishi Nag; Michael Nuhn; Anne Parker; Mateus Patricio; Miguel Pignatelli; Matthew Rahtz; Harpreet Singh Riat; Daniel Sheppard; Kieron Taylor; Anja Thormann; Alessandro Vullo; Steven P Wilder; Amonida Zadissa; Ewan Birney; Jennifer Harrow; Matthieu Muffato; Emily Perry; Magali Ruffier; Giulietta Spudich; Stephen J Trevanion; Fiona Cunningham; Bronwen L Aken; Daniel R Zerbino; Paul Flicek
Journal:  Nucleic Acids Res       Date:  2015-12-19       Impact factor: 16.971

8.  STAT2 is an essential adaptor in USP18-mediated suppression of type I interferon signaling.

Authors:  Kei-Ichiro Arimoto; Sara Löchte; Samuel A Stoner; Christoph Burkart; Yue Zhang; Sayuri Miyauchi; Stephan Wilmes; Jun-Bao Fan; Jürgen J Heinisch; Zhi Li; Ming Yan; Sandra Pellegrini; Frédéric Colland; Jacob Piehler; Dong-Er Zhang
Journal:  Nat Struct Mol Biol       Date:  2017-02-06       Impact factor: 15.369

9.  BACH2 represses effector programs to stabilize T(reg)-mediated immune homeostasis.

Authors:  Rahul Roychoudhuri; Kiyoshi Hirahara; Kambiz Mousavi; David Clever; Christopher A Klebanoff; Michael Bonelli; Giuseppe Sciumè; Hossein Zare; Golnaz Vahedi; Barbara Dema; Zhiya Yu; Hui Liu; Hayato Takahashi; Mahadev Rao; Pawel Muranski; Joseph G Crompton; George Punkosdy; Davide Bedognetti; Ena Wang; Victoria Hoffmann; Juan Rivera; Francesco M Marincola; Atsushi Nakamura; Vittorio Sartorelli; Yuka Kanno; Luca Gattinoni; Akihiko Muto; Kazuhiko Igarashi; John J O'Shea; Nicholas P Restifo
Journal:  Nature       Date:  2013-06-02       Impact factor: 49.962

10.  Human intracellular ISG15 prevents interferon-α/β over-amplification and auto-inflammation.

Authors:  Xianqin Zhang; Dusan Bogunovic; Béatrice Payelle-Brogard; Véronique Francois-Newton; Scott D Speer; Chao Yuan; Stefano Volpi; Zhi Li; Ozden Sanal; Davood Mansouri; Ilhan Tezcan; Gillian I Rice; Chunyuan Chen; Nahal Mansouri; Seyed Alireza Mahdaviani; Yuval Itan; Bertrand Boisson; Satoshi Okada; Lu Zeng; Xing Wang; Hui Jiang; Wenqiang Liu; Tiantian Han; Delin Liu; Tao Ma; Bo Wang; Mugen Liu; Jing-Yu Liu; Qing K Wang; Dilek Yalnizoglu; Lilliana Radoshevich; Gilles Uzé; Philippe Gros; Flore Rozenberg; Shen-Ying Zhang; Emmanuelle Jouanguy; Jacinta Bustamante; Adolfo García-Sastre; Laurent Abel; Pierre Lebon; Luigi D Notarangelo; Yanick J Crow; Stéphanie Boisson-Dupuis; Jean-Laurent Casanova; Sandra Pellegrini
Journal:  Nature       Date:  2014-10-12       Impact factor: 49.962

View more
  28 in total

Review 1.  Epigenetic regulation of T helper cells and intestinal pathogenicity.

Authors:  Yuya Hagihara; Yusuke Yoshimatsu; Yohei Mikami; Yoshiaki Takada; Shinta Mizuno; Takanori Kanai
Journal:  Semin Immunopathol       Date:  2019-03-19       Impact factor: 9.623

2.  Checkpoint Blockade Immunotherapy Induces Dynamic Changes in PD-1-CD8+ Tumor-Infiltrating T Cells.

Authors:  Sema Kurtulus; Asaf Madi; Giulia Escobar; Max Klapholz; Jackson Nyman; Elena Christian; Mathias Pawlak; Danielle Dionne; Junrong Xia; Orit Rozenblatt-Rosen; Vijay K Kuchroo; Aviv Regev; Ana C Anderson
Journal:  Immunity       Date:  2019-01-08       Impact factor: 31.745

3.  T-bet Transcription Factor Promotes Antibody-Secreting Cell Differentiation by Limiting the Inflammatory Effects of IFN-γ on B Cells.

Authors:  Sara L Stone; Jessica N Peel; Christopher D Scharer; Christopher A Risley; Danielle A Chisolm; Michael D Schultz; Bingfei Yu; André Ballesteros-Tato; Wojciech Wojciechowski; Betty Mousseau; Ravi S Misra; Adedayo Hanidu; Huiping Jiang; Zhenhao Qi; Jeremy M Boss; Troy D Randall; Scott R Brodeur; Ananda W Goldrath; Amy S Weinmann; Alexander F Rosenberg; Frances E Lund
Journal:  Immunity       Date:  2019-05-07       Impact factor: 31.745

4.  IFNγ induces epigenetic programming of human T-bethi B cells and promotes TLR7/8 and IL-21 induced differentiation.

Authors:  Esther Zumaquero; Sara L Stone; Christopher D Scharer; Scott A Jenks; Anoma Nellore; Betty Mousseau; Antonio Rosal-Vela; Davide Botta; John E Bradley; Wojciech Wojciechowski; Travis Ptacek; Maria I Danila; Jeffrey C Edberg; S Louis Bridges; Robert P Kimberly; W Winn Chatham; Trenton R Schoeb; Alexander F Rosenberg; Jeremy M Boss; Ignacio Sanz; Frances E Lund
Journal:  Elife       Date:  2019-05-15       Impact factor: 8.140

5.  RNA-binding protein YTHDF3 suppresses interferon-dependent antiviral responses by promoting FOXO3 translation.

Authors:  Yuan Zhang; Xin Wang; Xiao Zhang; Jiaming Wang; Yuanwu Ma; Lianfeng Zhang; Xuetao Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-27       Impact factor: 11.205

Review 6.  The evolving role of T-bet in resistance to infection.

Authors:  Gretchen Harms Pritchard; Ross M Kedl; Christopher A Hunter
Journal:  Nat Rev Immunol       Date:  2019-06       Impact factor: 53.106

7.  The liver-brain-gut neural arc maintains the Treg cell niche in the gut.

Authors:  Toshiaki Teratani; Yohei Mikami; Nobuhiro Nakamoto; Takahiro Suzuki; Yosuke Harada; Koji Okabayashi; Yuya Hagihara; Nobuhito Taniki; Keita Kohno; Shinsuke Shibata; Kentaro Miyamoto; Harumichi Ishigame; Po-Sung Chu; Tomohisa Sujino; Wataru Suda; Masahira Hattori; Minoru Matsui; Takaharu Okada; Hideyuki Okano; Masayuki Inoue; Toshihiko Yada; Yuko Kitagawa; Akihiko Yoshimura; Mamoru Tanida; Makoto Tsuda; Yusaku Iwasaki; Takanori Kanai
Journal:  Nature       Date:  2020-06-11       Impact factor: 49.962

8.  Shared transcriptional profiles of atypical B cells suggest common drivers of expansion and function in malaria, HIV, and autoimmunity.

Authors:  Prasida Holla; Brian Dizon; Abhijit A Ambegaonkar; Noga Rogel; Ella Goldschmidt; Arun K Boddapati; Haewon Sohn; Dan Sturdevant; James W Austin; Lela Kardava; Li Yuesheng; Poching Liu; Susan Moir; Susan K Pierce; Asaf Madi
Journal:  Sci Adv       Date:  2021-05-26       Impact factor: 14.136

Review 9.  The Effects of Interferons on Allogeneic T Cell Response in GVHD: The Multifaced Biology and Epigenetic Regulations.

Authors:  Chenchen Zhao; Yi Zhang; Hong Zheng
Journal:  Front Immunol       Date:  2021-07-08       Impact factor: 7.561

10.  STAT4 and T-bet control follicular helper T cell development in viral infections.

Authors:  Jason S Weinstein; Brian J Laidlaw; Yisi Lu; Jessica K Wang; Vincent P Schulz; Ningcheng Li; Edward I Herman; Susan M Kaech; Patrick G Gallagher; Joe Craft
Journal:  J Exp Med       Date:  2017-12-06       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.